A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

April 30, 2016

Conditions
Temporomandibular Joint DysfunctionPainArthrocentesis
Interventions
DRUG

Hyaluronic acid

1 cc hyalgan to be injected into superior joint space

DRUG

Corticosteroid

1cc celestone (6 mg/cc) will be injected into the joint space

DRUG

Lactated Ringers

1 cc lactated ringers solution will be injected into the joint space

Trial Locations (5)

19104

University of Pennsylvania, Philadelphia

30322

Emory University, Atlanta

45219

University of Cinncinati, Cinncinati

90024

University California Los Angeles, Los Angeles

97239

Oregon Health Sciences University, Portland

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

Oregon Health and Science University

OTHER

collaborator

University of Minnesota

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

University of Pennsylvania

OTHER

lead

Emory University

OTHER

NCT01524913 - A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction | Biotech Hunter | Biotech Hunter